Please login to the form below
1
Revenue 2017Humira
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.
Allergan investors back AbbVie deal, but is a tax charge looming?
The merger agreement came as AbbVie is facing pressure to diversify its portfolio and reduce its reliance on blockbuster drug Humira (adalimumab) – currently the world’s best-selling medicine – which is ... AbbVie says the deal adds $16bn in annual
In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq
The finding dented AbbVie’s hopes of growing sales of Rinvoq to offset the anticipated loss of Humira revenues to biosimilar competitors. ... ICER now calculates that the cost per month in remission on Rinvoq compared to Humira is $600.
J&J's Tremfya filed for approval in US for psoriatic arthritis
Lilly’s Taltz has also been proved to be superior to market leader Humira (adalimumab), in reducing psoriatic arthritis activity by half, and also completely cleared patient’s skin after 24 ... AbbVie’s Humira and J&J’s Stelara have remained
AbbVie/Allergan's merger faces public opposition
protection for its $20bn immunology blockbuster Humira.
Strike three for Rova-T has AbbVie cutting its losses
reduce its reliance on $20bn blockbuster TNF inhibitor Humira (adalimumab).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
-
Senior Copywriter
-
Salary TBC
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Novartis bags US okay for Lucentis follow-up Beovu in wet AMD
- GSK forms cell therapy R&D pact with star-studded biotech
- UCB gets bigger in rare diseases with $2.1bn purchase of Ra Pharma
- Merck seeks partner for disease-modifying osteoarthritis drug
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- Allergan investors back AbbVie deal, but is a tax charge looming?
- Wilmington Healthcare appoints new consultants
- J&J proposes $4bn in cash to settle opioid crisis allegations
- Eye for Pharma Marketing and Customer Innovation Europe
- Gilead promotes Andrew Dickinson to CFO, increased M&A expected
- Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial
- Alexion eyes Soliris combo with $930m deal to buy Achillion
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- Eye for Pharma Marketing and Customer Innovation Europe
- By Richard Springham...
- The Golden Goose
- Why it’s so hard for the US to curb runaway drug prices...
- What is changing in cardiovascular disease care?
- Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
Quick links
Infographics
